Partnerships and studies illustrate AI’s expanding role in biotech: Sartorius Stedim Biotech and Nanotein Technologies collaborate to boost immune cell expansion for cell therapy applications via soluble activators enhancing T and NK cell yields. Meanwhile, Mount Sinai unveiled an AI model capable of predicting hospital admissions from emergency department data earlier than existing methods, promising improvements in patient flow and care management. These developments underscore AI’s utility in manufacturing efficiency and clinical decision support.